Scholarly Index
Ryan C. Ungaro
Icahn School of Medicine at Mount Sinai; 12,883 total citations; 491 total publications; best world rank #19
Icahn School of Medicine at Mount Sinai
12,883Total citations
491Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 and healthcare impacts | Lifetime | 139 | US 50 | 97.48 |
| Inflammatory Bowel Disease | Lifetime | 228 | US 68 | 98.86 |
| COVID-19 Clinical Research Studies | Lifetime | 577 | US 141 | 97.87 |
| Microscopic Colitis | Lifetime | 240 | US 71 | 98.69 |
| Eosinophilic Esophagitis | Lifetime | 623 | US 227 | 97.11 |
| Autoimmune and Inflammatory Disorders | Lifetime | 319 | US 98 | 95.56 |
| Inflammatory Bowel Disease | 2021-2025 | 19 | US 8 | 99.72 |
| Microscopic Colitis | 2021-2025 | 21 | US 8 | 99.64 |
| COVID-19 Clinical Research Studies | 2021-2025 | 841 | US 197 | 96.50 |
| COVID-19 and healthcare impacts | 2021-2025 | 334 | US 112 | 94.41 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 40 | US 15 | 96.19 |
| Eosinophilic Esophagitis | 2021-2025 | 146 | US 63 | 96.42 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 243 | US 73 | 94.09 |
| Diverticular Disease and Complications | 2021-2025 | 240 | US 59 | 88.28 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 235 | US 40 | 83.49 |
| Liver Diseases and Immunity | 2021-2025 | 590 | US 142 | 83.01 |
| Celiac Disease Research and Management | 2021-2025 | 404 | US 59 | 78.19 |